Cathepsin D—managing the delicate balance

O Mijanovic, AI Petushkova, A Brankovic, B Turk… - Pharmaceutics, 2021 - mdpi.com
Lysosomal proteases play a crucial role in maintaining cell homeostasis. Human cathepsin
D manages protein turnover degrading misfolded and aggregated proteins and favors …

[HTML][HTML] Advances in amyloid-β clearance in the brain and periphery: implications for neurodegenerative diseases

R Ullah, EJ Lee - Experimental Neurobiology, 2023 - ncbi.nlm.nih.gov
This review examines the role of impaired amyloid-β clearance in the accumulation of
amyloid-β in the brain and the periphery, which is closely associated with Alzheimer's …

Biomarkers in 5q-associated spinal muscular atrophy—a narrative review

HS Lapp, M Freigang, T Hagenacker, M Weiler… - Journal of …, 2023 - Springer
Abstract 5q-associated spinal muscular atrophy (SMA) is a rare genetic disease caused by
mutations in the SMN1 gene, resulting in a loss of functional SMN protein and consecutive …

Insulin-degrading enzyme: Paradoxes and possibilities

MA Leissring - Cells, 2021 - mdpi.com
More than seven decades have passed since the discovery of a proteolytic activity within
crude tissue extracts that would become known as insulin-degrading enzyme (IDE) …

Proteolytic α-synuclein cleavage in health and disease

A Bluhm, S Schrempel, S Hörsten, A Schulze… - International journal of …, 2021 - mdpi.com
In Parkinson's disease, aggregates of α-synuclein within Lewy bodies and Lewy neurites
represent neuropathological hallmarks. However, the cellular and molecular mechanisms …

Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy

DC Schorling, H Kölbel, A Hentschel… - European journal of …, 2022 - Wiley Online Library
Background and purpose The therapeutic landscape of spinal muscular atrophy (SMA) has
changed dramatically during the past 4 years, but treatment responses differ remarkably …

Experimental approaches for altering the expression of Abeta‐degrading enzymes

DA Loeffler - Journal of neurochemistry, 2023 - Wiley Online Library
Cerebral clearance of amyloid β‐protein (Aβ) is decreased in early‐onset and late‐onset
Alzheimer's disease (AD). Aβ is cleared from the brain by enzymatic degradation and by …

Exercise rehabilitation and/or astragaloside attenuate amyloid-beta pathology by reversing BDNF/TrkB signaling deficits and mitochondrial dysfunction

YL Wang, CC Chio, SC Kuo, CH Yeh, JT Ma… - Molecular …, 2022 - Springer
We aim to investigate the mechanisms underlying the beneficial effects of exercise
rehabilitation (ER) and/or astragaloside (AST) in counteracting amyloid-beta (Aβ) pathology …

Cathepsin B abundance, activity and microglial localisation in Alzheimer's disease-Down syndrome and early onset Alzheimer's disease; the role of elevated cystatin …

Y Wu, P Mumford, S Noy, K Cleverley… - Acta Neuropathologica …, 2023 - Springer
Cathepsin B is a cysteine protease that is implicated in multiple aspects of Alzheimer's
disease pathogenesis. The endogenous inhibitor of this enzyme, cystatin B (CSTB) is …

[HTML][HTML] Cathepsin D overexpression in the nervous system rescues lethality and Aβ42 accumulation of cathepsin D systemic knockout in vivo

X Ouyang, WY Wani, GA Benavides… - … Pharmaceutica Sinica B, 2023 - Elsevier
The lysosome is responsible for protein and organelle degradation and homeostasis and
the cathepsins play a key role in maintaining protein quality control. Cathepsin D (CTSD), is …